Bank of America Global Healthcare Conference 2026 May 12, 2026 6:00 PM EDTCompany ParticipantsRoland Sackers - CFO, MD & Member ...

Builds on approximately $300 million returned to shareholders in early 2024 as part of commitment to return at least $1 billion through end-2028 VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V.

Co-founder and former CEO Dr. Metin Colpan to become Honorary Chairman of the Supervisory Board after deciding not to stand ...

The law firm of Kirby McInerney LLP is investigating potential claims against Qiagen N.V. ("Qiagen" or the "Company") (NYSE:QGEN). The investigation concerns whether the Company a ...

Have you assessed how the international operations of Qiagen (QGEN) performed in the quarter ended March 2026? For this diagnostic products maker, possessing an expansive global footprint, parsing the ...

Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing May 7, 2026 9:30 AM ...

Recent share performance and business profile Qiagen (QGEN) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, ...

Thank you, Dominica, and good morning, good afternoon, good evening, to all of you. Thanks again for your attention and interest in Qiagen N.V. A year ago, and I hope and I think that most of you ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis (TB) test with a new fully automated Sample to Insight workflow and a ...